Form D · Biotechnology
BIOCEPT INC
San Diego, CA · CIK 0001044378
Offering snapshot reported Jun 6, 2019 · SEC filing
- Reported sold
- $0 Offering amount: $10.1M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 30, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 6, 2019 | Initial | $0 | No comparison | 7 | SEC filing |
| Mar 29, 2019 | Initial | $0 | No comparison | 7 | SEC filing |
| Oct 3, 2018 | Initial | $0 | No comparison | 4 | SEC filing |
| Aug 14, 2017 | Initial | $2,200,000 | No comparison | 1 | SEC filing |
| Apr 10, 2017 | Initial | $0 | No comparison | 13 | SEC filing |
| Dec 23, 2015 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Feb 16, 2011 | Initial | $1,200,000 | No comparison | 1 | SEC filing |
| Aug 12, 2010 | Initial | $2,299,999 | No comparison | 1 | SEC filing |
| Mar 29, 2010 | Initial | $3,600,000 | No comparison | 4 | SEC filing |
| Jul 10, 2009 | Initial | $3,000 | No comparison | 1 | SEC filing |
| Feb 24, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 3, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 10, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 28, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 1, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 16, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 9, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 9, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-341255
Represents amounts receivable upon exercise of warrants to purchase shares of Common Stock; such warrants have not yet been exercised.
Upon receipt of gross proceeds from the exercise of the Warrants, Biocept shall pay a solicitation fee ranging from 4% to 7% of such gross proceeds. In addition, expenses are to be reimbursed. Both amounts are indeterminable at this time.
Source: Form D, filed Jun 6, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lyle Arnold | Executive |
| Farideh Bischoff | Executive |
| Marsha A. Chandler | Director |
| Stephen Coutts | Director, Executive |
| Jennifer K. Crittenden | Executive |
| Edward Dennis | Director |
| Mark Foletta | Executive |
| Bruce E. Gerhardt | Director |
| David Hale | Director |
| Edwin Hendrick | Executive |
| Bruce Huebner | Director |
| Todd Johnson | Executive |
| Timothy Kennedy | Executive |
| Tim Kennedy | Executive |
| Meg Mc Gilley | Executive |
| Michael Nall | Director, Executive |
| Edward Neff | Director |
| Ed Neff | Director |
| Aaron Nepper | Director |
| Daniel Petree | Director |
| Claire Reiss | Director |
| Ivor Royston | Director |
| Veena Singh | Executive |
| Michael Terry | Executive |
| Raaj Trivedi | Executive |
| M. Faye Wilson | Director |
| M Faye Wilson | Director |
| Faye Wilson | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5810 Nancy Ridge Dr
San Diego, CA, 92121
San Diego, CA, 92121